Jaume Capdevila

基本信息

Career Trajectory

Bio

He is an active member of several oncology societies (ASCO, ENETS, EORTC, SEOM, TTD, GEMCAD, GETNE, and GETHI) and actively participates in national and international trials. He is member of the advisory board of the European Neuroendocrine Tumor Society (ENETS), Secretary and Treasurer of the Spanish Task Force for neuroendocrine tumors (Grupo Español de Tumores Neuroendocrinos, GETNE) and funding member and Treasurer of the Spanish Task Force Group for Research in Orphan and Rare Tumors (Grupo Español de Tumores Huérfanos e Infrecuentes, GETHI). He is also the medical oncologist member of the Thyroid Cancer Working Group within the Spanish Society of Endocrinology and Nutrition (SEEN).

Research Interests

Papers共 495 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Genomics Review of Selective RET Inhibitors Sensitivity in Thyroid Cancer Clinical Trials

Sara Gil-Bernabé, Lucía García-DeLaFuente, Alejandro García-Álvarez, Ginesa García-Rostán,Jaume Capdevila, Jorge Hernando

American journal of medical genetics Part C, Seminars in medical geneticspp.e32127-e32127, (2025)

Cited0Views0WOSBibtex

Systematic Literature Review (SLR) of Prognostic Factors (pfs) in Locally Advanced Rectal Cancer (LARC) and Mismatch Repair Deficient (dmmr)/microsatellite Instability-High (MSI-H) Rectal Cancer (RC)

Jaume Capdevila, Sean O’Donnell, Katarzyna Borkowska, James Frampton,Marissa Betts, Courtney Maierhofer, Linda Kalilani, Jamie Garside, Huifen Wang

Journal of Clinical Oncologyno. 4_suppl (2025): 303-303

Cited0Views0Bibtex

Matching Adjusted Indirect Comparison (MAIC) of 177 Lu-DOTATATE Vs. Sunitinib As First-Line (1L) Treatment for Advanced Grade 2 (G2) Pancreatic Neuroendocrine Tumors (Pnets)

Raj Srirajaskanthan,Jaume Capdevila,Emmanuel Deshayes,Shaunak Navalkissoor,Ilya Folitar, Marcos Lovelle, Thomas Delea, Subhajit Gupta, Anup Kumar, Purnima Pathak

Journal of Clinical Oncologyno. 4_suppl (2025): 664-664

Cited0Views0Bibtex

A Systematic Literature Review of Studies Assessing First-Line (1L) Treatments in Patients with Advanced, Grade 2/3 (G2/G3) Gastroenteropancreatic Neuroendocrine Tumors (Gep-Nets)

Jaume Capdevila,Emmanuel Deshayes,Shaunak Navalkissoor,Raj Srirajaskanthan,Ilya Folitar, Marcos Lovelle, Deepali Soni, Udaya Sri Lakkakula, Parth Joshi, Purnima Pathak

Journal of Clinical Oncologyno. 4_suppl (2025): 663-663

Cited0Views0Bibtex

Unraveling the RNA Landscape of Small Intestine Neuroendocrine Neoplasms Applying Transcriptomic and Spliceosomic Perspectives

A. Ibanez-Costa, S. Pedraza-Arevalo,Montilla M. T. Moreno,J. Hernando,A. Garcia,A. Garcia-Alvarez,S. Landolfi, Cuso L. Blanco,A. Casteras,A. Vivancos,J. Capdevila,J. P. Castano

JOURNAL OF NEUROENDOCRINOLOGY (2024): 26-26

Cited0Views0Bibtex

Treatment of Advanced BP-NETS with Lanreotide Autogel/Depot Vs Placebo: the Phase III SPINET Study

E. Baudin,J. Capdevila, D. Hoersch,S. Singh,M. E. Caplin,E. M. Wolin,W. Buikhuisen,M. Raderer,E. Dansin,C. Grohe,D. Ferone,A. Houchard,X-M Truong-Thanh,D. Reidy-Lagunes

ENDOCRINE-RELATED CANCERno. 9 (2024)

Cited0Views0WOSBibtex

Abstract CT090: DAREON™-7: A Phase 1, Open-Label, Dose Escalation and Expansion Cohort Trial of the Delta-Like Ligand (Dll3)-Targeting T-cell Engager BI 764532, Plus First-Line Platinum-Based Chemotherapy in Patients with DLL3-positive (+) Neuroendocrine Carcinomas

Jaume Capdevila,Timon Vandamme,Patricia Niccoli,Saori Mishima,Ken Kato, Yiyuan Ma, Ping Sun, Lidan Geng, Ulrich M. Lauer

Cancer Researchno. 7_Supplement (2024): CT090-CT090

Cited0Views0Bibtex

Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study

Laurent Mortier,Lisa Villabona,Ben Lawrence,Ana Arance,Marcus O. Butler,Marie Beylot-Barry,Philippe Saiag,Mahtab Samimi,Paolo A. Ascierto,Francesca Spada, Michel De Pontville,Michele Maio,Alfonso Berrocal,Enrique Espinosa,Jaume Capdevila,Max Levin, Debasmita Das,Clemens Krepler,Dmitri Grebennik,Vanna Chiarion-Sileni

AMERICAN JOURNAL OF CLINICAL DERMATOLOGYno. 6 (2024): 987-996

Cited0Views0WOSBibtex

Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer (Apr, 10.1148/ryai.249001, 2024)

Olivia Prior,Carlos Macarro,Victor Navarro, Camilo Monreal,Marta Ligero,Alonso Garcia-Ruiz,Garazi Serna,Sara Simonetti,Irene Brana,Maria Vieito,Manuel Escobar,Jaume Capdevila,Annette T. Byrne,Rodrigo Dienstmann,Rodrigo Toledo,Paolo Nuciforo,Elena Garralda,Francesco Grussu,Kinga Bernatowicz,Raquel Perez-Lopez

RADIOLOGY-ARTIFICIAL INTELLIGENCEno. 3 (2024)

Cited0Views0Bibtex

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Jaume Capdevila,Jolanta Krajewska,Jorge Hernando,Bruce Robinson,Steven I. Sherman,Barbara Jarzab,Chia-Chi Lin,Fernanda Vaisman,Ana O. Hoff,Erika Hitre,Daniel W. Bowles, Denise Williamson, Roman Levytskyy,Jennifer Oliver,Bhumsuk Keam,Marcia S. Brose

THYROID（2024）

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Senior Researcher

Papers共 495 篇Author StatisticsCo-AuthorSimilar Experts